Fasano RM (February 2016). "Hemolytic disease of the fetus and newborn in the molecular era". Seminars in Fetal & Neonatal Medicine. 21 (1): 28–34. doi:10.1016/j.siny.2015.10.006. PMID26589360.
Finning K, Martin P, Summers J, Daniels G (November 2007). "Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma". Transfusion. 47 (11): 2126–2133. doi:10.1111/j.1537-2995.2007.01437.x. PMID17958542. S2CID8292568.
Scheffer PG, van der Schoot CE, Page-Christiaens GC, de Haas M (October 2011). "Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience". BJOG. 118 (11): 1340–1348. doi:10.1111/j.1471-0528.2011.03028.x. PMID21668766. S2CID32946225.
Levine P, Stetson RE (1939). "An Unusual Case of Intra-Group Agglutination". Journal of the American Medical Association. 113 (2): 126–7. doi:10.1001/jama.1939.72800270002007a.
Landsteiner K, Wiener AS (1940). "An Agglutinable Factor in Human Blood Recognized by Immune Sera for Rhesus Blood". Experimental Biology and Medicine. 43: 223. doi:10.3181/00379727-43-11151. S2CID58298368.
Freda VJ, Gorman JG, Pollack W (January 1964). "Successful Prevention of Experimental Rh Sensitization in Man With an Anti-Rh gamma2-Globulin Antibody Preparation: A Preliminary Report". Transfusion. 4: 26–32. doi:10.1111/j.1537-2995.1964.tb02824.x. PMID14105934. S2CID35474015.
Fasano RM (February 2016). "Hemolytic disease of the fetus and newborn in the molecular era". Seminars in Fetal & Neonatal Medicine. 21 (1): 28–34. doi:10.1016/j.siny.2015.10.006. PMID26589360.
Finning K, Martin P, Summers J, Daniels G (November 2007). "Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma". Transfusion. 47 (11): 2126–2133. doi:10.1111/j.1537-2995.2007.01437.x. PMID17958542. S2CID8292568.
Scheffer PG, van der Schoot CE, Page-Christiaens GC, de Haas M (October 2011). "Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience". BJOG. 118 (11): 1340–1348. doi:10.1111/j.1471-0528.2011.03028.x. PMID21668766. S2CID32946225.
Freda VJ, Gorman JG, Pollack W (January 1964). "Successful Prevention of Experimental Rh Sensitization in Man With an Anti-Rh gamma2-Globulin Antibody Preparation: A Preliminary Report". Transfusion. 4: 26–32. doi:10.1111/j.1537-2995.1964.tb02824.x. PMID14105934. S2CID35474015.
Finning K, Martin P, Summers J, Daniels G (November 2007). "Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma". Transfusion. 47 (11): 2126–2133. doi:10.1111/j.1537-2995.2007.01437.x. PMID17958542. S2CID8292568.
Scheffer PG, van der Schoot CE, Page-Christiaens GC, de Haas M (October 2011). "Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience". BJOG. 118 (11): 1340–1348. doi:10.1111/j.1471-0528.2011.03028.x. PMID21668766. S2CID32946225.
Landsteiner K, Wiener AS (1940). "An Agglutinable Factor in Human Blood Recognized by Immune Sera for Rhesus Blood". Experimental Biology and Medicine. 43: 223. doi:10.3181/00379727-43-11151. S2CID58298368.
Freda VJ, Gorman JG, Pollack W (January 1964). "Successful Prevention of Experimental Rh Sensitization in Man With an Anti-Rh gamma2-Globulin Antibody Preparation: A Preliminary Report". Transfusion. 4: 26–32. doi:10.1111/j.1537-2995.1964.tb02824.x. PMID14105934. S2CID35474015.